Evidence-based strategies for the characterisation of human drug and chemical glucuronidation in vitro and UDP-glucuronosyltransferase reaction phenotyping

JO Miners, A Rowland, JJ Novak, K Lapham… - Pharmacology & …, 2021 - Elsevier
Enzymes of the UDP-glucuronosyltransferase (UGT) superfamily contribute to the
elimination of drugs from almost all therapeutic classes. Awareness of the importance of …

The Uridine diphosphate (UDP)-glycosyltransferases (UGTs) superfamily: the role in tumor cell metabolism

W Liu, J Li, R Zhao, Y Lu, P Huang - Frontiers in Oncology, 2023 - frontiersin.org
UDP-glycosyltransferases (UGTs), important enzymes in biotransformation, control the
levels and distribution of numerous endogenous signaling molecules and the metabolism of …

Enhanced bioavailability and hepatoprotective effect of silymarin by preparing silymarin-loaded solid dispersion formulation using freeze-drying method

DY Lim, M Pang, J Lee, J Lee, JH Jeon, JH Park… - Archives of Pharmacal …, 2022 - Springer
This study aimed to develop a solid dispersion formulation of silymarin (Silymarin-SD) using
freeze-drying method to enhance its oral bioavailability (BA) by inhibiting the intestinal first …

Herb–Drug interaction of red ginseng extract and ginsenoside Rc with valsartan in rats

JH Jeon, S Lee, W Lee, S Jin, M Kwon, CH Shin… - Molecules, 2020 - mdpi.com
The purpose of this study was to investigate the herb–drug interactions involving red
ginseng extract (RGE) or ginsenoside Rc with valsartan, a substrate for organic anion …

[HTML][HTML] Bioanalytical method validation, biopharmaceutical and pharmacokinetic evaluation of GSK-650394, a serum-and glucocorticoid-regulated kinase 1 inhibitor

QD Le, VA Duong, SH Lee, HJ Maeng - Arabian Journal of Chemistry, 2023 - Elsevier
GSK-650394 is an inhibitor of serum-and glucocorticoid-regulated kinase 1 that displays
potency for treating cancer, hypertension, cardiovascular and neuronal diseases, such as …

Strong and selective inhibitory effects of the biflavonoid selamariscina A against CYP2C8 and CYP2C9 enzyme activities in human liver microsomes

SY Park, PH Nguyen, G Kim, SN Jang, GH Lee… - Pharmaceutics, 2020 - mdpi.com
Like flavonoids, biflavonoids, dimeric flavonoids, and polyphenolic plant secondary
metabolites have antioxidant, antibacterial, antiviral, anti-inflammatory, and anti-cancer …

Contributions of UDP-glucuronosyltransferases to human hepatic and intestinal metabolism of ticagrelor and inhibition of UGTs and cytochrome P450 enzymes by …

S Liu, L Hou, C Li, Y Zhao, X Yao, X Zhang… - Frontiers in …, 2021 - frontiersin.org
Ticagrelor is the first reversibly binding, direct-acting, oral P2Y12 receptor inhibitor. The
contribution of UDP-glucuronosyltransferases (UGTs) enzymes to the metabolism of …

[HTML][HTML] Ginsenoside Rc: A potential intervention agent for metabolic syndrome

Z Lu, T Mao, K Chen, L Chai, Y Dai, K Liu - Journal of pharmaceutical …, 2023 - Elsevier
Ginsenoside Rc, a dammarane-type tetracyclic triterpenoid saponin primarily derived from
Panax ginseng, has garnered significant attention due to its diverse pharmacological …

Research progress of herbal medicines on drug metabolizing enzymes: consideration based on toxicology

S Wang, W Li, J Yang, Z Yang, C Yang… - Current Drug …, 2020 - ingentaconnect.com
The clinical application of herbal medicines is increasing, but there is still a lack of
comprehensive safety data and in-depth research into mechanisms of action. The …

Methylophiopogonanone A is a naturally occurring broad‐spectrum inhibitor against human UDP‐glucuronosyltransferases: Inhibition behaviours and implication in …

QH Zhou, GH Zhu, YQ Song, YF Que… - Basic & Clinical …, 2021 - Wiley Online Library
Methylophiopogonanone A (MOA) is an abundant homoisoflavonoid in the Chinese herb
Ophiopogonis Radix. Recent investigations revealed that MOA inhibited several human …